P465 Is golimumab serum level predictive of clinical remission after intensification for loss of response in patients with ulcerative colitis? - Vigipallia

0 avis

P465 Is golimumab serum level predictive of clinical remission after intensification for loss of response in patients with ulcerative colitis?

Archive ouverte

Fumery, Mathurin | Nancey, S. | Filippi, J. | Altwegg, R. | Hebuterne, X. | Boschetti, G. | Veyrard, P. | Yzet, Clara | Paul, S. | Roblin, X.

Edité par CCSD ; Elsevier - Oxford University Press -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis

Archive ouverte | Veyrard, P. | CCSD

International audience

Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)

Archive ouverte | Buisson, A. | CCSD

European Crohn's and Colitis Organisation - ECCO. Poster presentations: Clinical: Therapy and Observation 2020. International audience

Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

Archive ouverte | Amiot, A. | CCSD

International audience

Chargement des enrichissements...